ArticleJournal of nanobiotechnology2026
Cross-species hybrid vesicles enable synergistic immunochemotherapy through enhanced targeted drug delivery and immune activation.
Zhou Fang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.